95 related articles for article (PubMed ID: 19478941)
21. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
[TBL] [Abstract][Full Text] [Related]
22. *K-means and cluster models for cancer signatures.
Kakushadze Z; Yu W
Biomol Detect Quantif; 2017 Sep; 13():7-31. PubMed ID: 29021969
[TBL] [Abstract][Full Text] [Related]
23. Integration of ALV into
Winans S; Flynn A; Malhotra S; Balagopal V; Beemon KL
Oncotarget; 2017 Aug; 8(34):57302-57315. PubMed ID: 28915671
[TBL] [Abstract][Full Text] [Related]
24. Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity.
Pruikkonen S; Kallio MJ
Br J Cancer; 2017 May; 116(11):1451-1461. PubMed ID: 28449010
[TBL] [Abstract][Full Text] [Related]
25. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
26. Clusters of Multiple Mutations: Incidence and Molecular Mechanisms.
Chan K; Gordenin DA
Annu Rev Genet; 2015; 49():243-67. PubMed ID: 26631512
[TBL] [Abstract][Full Text] [Related]
27. Lentivirus-mediated silencing of USO1 inhibits cell proliferation and migration of human colon cancer cells.
Sui J; Li X; Xing J; Cao F; Wang H; Gong H; Zhang W
Med Oncol; 2015 Aug; 32(8):218. PubMed ID: 26184508
[TBL] [Abstract][Full Text] [Related]
28. Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes.
Kandi R; Gutti U; Undi R; Sahu I; Gutti RK
J Thromb Thrombolysis; 2015 Oct; 40(3):310-6. PubMed ID: 26055579
[TBL] [Abstract][Full Text] [Related]
29. MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia.
Zhang L; Li X; Ke Z; Huang L; Liang Y; Wu J; Zhang X; Chen Y; Zhang H; Luo X
Cancer Cell Int; 2013 Nov; 13(1):110. PubMed ID: 24191888
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.
Shull AY; Clendenning ML; Ghoshal-Gupta S; Farrell CL; Vangapandu HV; Dudas L; Wilkerson BJ; Buckhaults PJ
PLoS One; 2013; 8(3):e58731. PubMed ID: 23505554
[TBL] [Abstract][Full Text] [Related]
31. NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.
Kashuba V; Dmitriev AA; Krasnov GS; Pavlova T; Ignatjev I; Gordiyuk VV; Gerashchenko AV; Braga EA; Yenamandra SP; Lerman M; Senchenko VN; Zabarovsky E
Int J Mol Sci; 2012 Oct; 13(10):13352-77. PubMed ID: 23202957
[TBL] [Abstract][Full Text] [Related]
32. RASSF1 Polymorphisms in Cancer.
Gordon M; El-Kalla M; Baksh S
Mol Biol Int; 2012; 2012():365213. PubMed ID: 22701175
[TBL] [Abstract][Full Text] [Related]
33. A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
Yee KS; Grochola L; Hamilton G; Grawenda A; Bond EE; Taubert H; Wurl P; Bond GL; O'Neill E
Cancer Res; 2012 May; 72(9):2206-17. PubMed ID: 22389451
[TBL] [Abstract][Full Text] [Related]
34. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.
Zheng YS; Zhang H; Zhang XJ; Feng DD; Luo XQ; Zeng CW; Lin KY; Zhou H; Qu LH; Zhang P; Chen YQ
Oncogene; 2012 Jan; 31(1):80-92. PubMed ID: 21643017
[TBL] [Abstract][Full Text] [Related]
35. Damage-induced localized hypermutability.
Burch LH; Yang Y; Sterling JF; Roberts SA; Chao FG; Xu H; Zhang L; Walsh J; Resnick MA; Mieczkowski PA; Gordenin DA
Cell Cycle; 2011 Apr; 10(7):1073-85. PubMed ID: 21406975
[TBL] [Abstract][Full Text] [Related]
36. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.
Kashuba VI; Pavlova TV; Grigorieva EV; Kutsenko A; Yenamandra SP; Li J; Wang F; Protopopov AI; Zabarovska VI; Senchenko V; Haraldson K; Eshchenko T; Kobliakova J; Vorontsova O; Kuzmin I; Braga E; Blinov VM; Kisselev LL; Zeng YX; Ernberg I; Lerman MI; Klein G; Zabarovsky ER
PLoS One; 2009 May; 4(5):e5231. PubMed ID: 19478941
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.
Senchenko VN; Anedchenko EA; Kondratieva TT; Krasnov GS; Dmitriev AA; Zabarovska VI; Pavlova TV; Kashuba VI; Lerman MI; Zabarovsky ER
BMC Cancer; 2010 Mar; 10():75. PubMed ID: 20193080
[TBL] [Abstract][Full Text] [Related]
38. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.
Kashuba VI; Li J; Wang F; Senchenko VN; Protopopov A; Malyukova A; Kutsenko AS; Kadyrova E; Zabarovska VI; Muravenko OV; Zelenin AV; Kisselev LL; Kuzmin I; Minna JD; Winberg G; Ernberg I; Braga E; Lerman MI; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4906-11. PubMed ID: 15051889
[TBL] [Abstract][Full Text] [Related]
39. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
